Literature DB >> 12681502

Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas.

Chad Creighton1, Samir Hanash, David Beer.   

Abstract

An analysis of microarray data from 86 lung adenocarcinomas reveals hundreds of genes significantly correlated with tumor cell differentiation. A bioinformatics approach of linking these genes to public information from the Locuslink and KEGG databases yields evidence for a loss of tumor cell differentiation being associated with biological processes of cell division, protein degradation, pyrimidine and purine metabolism, oxidative phosphorylation, glyoxylate and dicarboxylate metabolism, folate biosynthesis, and glutamate metabolism. The increased expression of genes involved in these processes is consistent with increased proliferation and metabolism characteristics of poorly differentiated tumors. The complete results of this analysis are available at http://dot.ped.med.umich.edu:2000/pub/diff/index.htm. Copyright 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies

Entities:  

Mesh:

Year:  2003        PMID: 12681502     DOI: 10.1016/s0014-5793(03)00259-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Cons: the confusing mucinous adenocarcinoma classification.

Authors:  Helmut H Popper
Journal:  Transl Lung Cancer Res       Date:  2017-04

2.  Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.

Authors:  Chad Creighton; Rork Kuick; David E Misek; David S Rickman; Franck M Brichory; Jean-Marie Rouillard; Gilbert S Omenn; Samir Hanash
Journal:  Genome Biol       Date:  2003-06-23       Impact factor: 13.583

3.  Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.

Authors:  Jens Neumann; Friedrich Feuerhake; Gian Kayser; Thorsten Wiech; Konrad Aumann; Bernward Passlick; Paul Fisch; Martin Werner; Axel Zur Hausen
Journal:  BMC Cancer       Date:  2010-03-02       Impact factor: 4.430

4.  Meta-analysis approaches to combine multiple gene set enrichment studies.

Authors:  Wentao Lu; Xinlei Wang; Xiaowei Zhan; Adi Gazdar
Journal:  Stat Med       Date:  2017-10-19       Impact factor: 2.373

5.  A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors.

Authors:  I-Tien Yeh; Romina E Lenci; Yuejuan Qin; Kalyan Buddavarapu; Azra H Ligon; Emmanuelle Leteurtre; Christine Do Cao; Catherine Cardot-Bauters; Pascal Pigny; Patricia L M Dahia
Journal:  Hum Genet       Date:  2008-08-26       Impact factor: 4.132

6.  Data mining for gene networks relevant to poor prognosis in lung cancer via backward-chaining rule induction.

Authors:  Mary E Edgerton; Douglas H Fisher; Lianhong Tang; Lewis J Frey; Zhihua Chen
Journal:  Cancer Inform       Date:  2007-02-10

7.  Leveraging global gene expression patterns to predict expression of unmeasured genes.

Authors:  James Rudd; René A Zelaya; Eugene Demidenko; Ellen L Goode; Casey S Greene; Jennifer A Doherty
Journal:  BMC Genomics       Date:  2015-12-15       Impact factor: 3.969

8.  Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.

Authors:  Yaowen Zhang; Jianpo Wang; Ningtao Dai; Peng Han; Jian Li; Jiangman Zhao; Weilan Yuan; Jiahuan Zhou; Fuyou Zhou
Journal:  BMC Cancer       Date:  2020-09-02       Impact factor: 4.430

9.  Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers.

Authors:  Yasmin M Vasquez; Fengju Chen; Yiqun Zhang; Diana Monsivais; Darshan S Chandrashekar; John C Faver; Ramya P Masand; Michael E Scheurer; Sooryanarayana Varambally; Martin M Matzuk; Chad J Creighton
Journal:  Oncogene       Date:  2021-02-24       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.